Authors

• Benjamin Li (ORCID: https://orcid.org/0000-0002-1783-7013)
• Lynn McRoy
• Adam Brufsky (ORCID: https://orcid.org/0000-0001-8080-7960)
• Doris Makari
• Rachel M. Layman (ORCID: https://orcid.org/0000-0002-8663-0331)
• Hope S. Rugo (ORCID: https://orcid.org/0000-0001-6710-4814)
• Xianchen Liu (ORCID: https://orcid.org/0000-0003-0411-1050)
• Connie Chen (ORCID: https://orcid.org/0000-0001-5384-4707)

Institutions

• The University of Texas MD Anderson Cancer Center (US)
• University of California, San Francisco (US)
• Pfizer (United States) (US)
• UPMC Hillman Cancer Center (US)
• University of Pittsburgh Medical Center (US)
• UCSF Helen Diller Family Comprehensive Cancer Center (US)

Publication Details

Journal

The Oncologist

Published

2024-10-17

DOI

https://doi.org/10.1093/oncolo/oyae273

Citations

3

Primary Topic

Advanced Breast Cancer Therapies

Type

article

Field-Weighted Citation Impact

1.26

Funders

• Pfizer